Spacelabs Healthcare Announces Agreement to Provide Its Rothman Index® to Hospitals and Health Systems Through DEPTH Health

Key Takeaways

• Spacelabs partners with DEPTH to embed Rothman Index.
• Index analyzes 26 data points for real‑time patient risk scoring.
• RACER platform will use insights to optimize bed allocation.
• Early deterioration detection can shorten hospital stays.
• Partnership reflects rising demand for AI clinical decision support.

Summary

Spacelabs Healthcare has signed an agreement with DEPTH Health to integrate its Rothman Index into DEPTH’s Real‑Time Advisor for Clinical Expert Routing (RACER) platform. The Rothman Index aggregates 26 clinical data points into a 200‑point risk score that updates continuously, helping clinicians spot early signs of patient deterioration. DEPTH will deliver this predictive tool to hospitals, aiming to improve patient flow, bed utilization, and clinical decision speed. The deal highlights the rising demand for AI‑driven decision‑support solutions in acute care settings.

Pulse Analysis

The Rothman Index, developed by Spacelabs Healthcare, aggregates 26 clinical variables—labs, vital signs, and nurse assessments—into a single 200‑point risk score that updates continuously as new data enter the electronic health record. This granular, real‑time view of patient acuity has been shown to flag subtle physiological shifts before overt deterioration, giving clinicians a valuable early‑warning tool. By embedding the Index within DEPTH Health’s Real‑Time Advisor for Clinical Expert Routing (RACER™), hospitals gain immediate access to predictive analytics without separate licensing, streamlining decision‑support workflows across existing EHR ecosystems.

From an operations perspective, the combined solution directly tackles two persistent challenges: bed scarcity and inefficient patient placement. RACER leverages the Index’s score to recommend when a patient should be escalated to intensive care or transitioned to a step‑down unit, enabling faster turnover of high‑acuity beds. Early identification of at‑risk patients can reduce average length of stay, lower readmission rates, and improve overall throughput—metrics that translate into measurable cost savings for health systems under value‑based reimbursement models. Moreover, the automation of routing decisions frees nursing staff to focus on bedside care rather than manual triage.

The partnership reflects a broader shift toward AI‑driven clinical decision support as hospitals seek to extract more value from the massive data streams generated by modern monitoring devices. While competitors offer proprietary early‑warning scores, Spacelabs’ open‑integration approach and DEPTH’s augmented surveillance intelligence give the duo a competitive edge in scalability and interoperability. Potential hurdles remain, such as ensuring data quality across disparate EHR platforms and navigating regulatory scrutiny of algorithmic recommendations. Nevertheless, the collaboration positions both companies to capitalize on the growing market for predictive patient‑flow solutions, a segment projected to expand rapidly as health systems prioritize efficiency and outcomes.